HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Luigi Bennardo Selected Research
Luigi Bennardo Research Topics
Disease
7
Psoriasis (Pustulosis Palmaris et Plantaris)
05/2021 - 11/2018
6
Cicatrix (Scar)
01/2022 - 02/2021
3
Atopic Dermatitis (Atopic Eczema)
01/2022 - 11/2018
3
COVID-19
11/2021 - 05/2021
3
Hyperpigmentation
09/2021 - 02/2021
3
Acne Vulgaris
02/2021 - 10/2018
2
Pruritus (Itching)
05/2022 - 01/2020
2
Inflammation (Inflammations)
05/2022 - 01/2019
2
Erythema
02/2022 - 02/2021
2
Infections
01/2022 - 05/2021
2
Melanoma (Melanoma, Malignant)
12/2021 - 04/2021
2
Alopecia (Baldness)
10/2021 - 10/2018
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2021 - 01/2021
2
Pain (Aches)
02/2021 - 09/2020
1
Telangiectasis (Telangiectasia)
05/2022
1
Stroke (Strokes)
05/2022
1
Prurigo
05/2022
1
Striae Distensae
03/2022
1
Delayed Hypersensitivity (Hypersensitivity, Type IV)
02/2022
1
Drug-Related Side Effects and Adverse Reactions
02/2022
1
Skin Diseases (Skin Disease)
01/2022
1
Cellulite
01/2022
1
Warts (Wart)
01/2022
1
Neurofibroma
01/2022
1
Basal Cell Carcinoma (Rodent Ulcer)
01/2022
1
Necrosis
01/2022
1
Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2022
1
Hidrocystoma
01/2022
1
Skin Neoplasms (Skin Cancer)
12/2021
1
Actinic Keratosis
12/2021
1
Chronic Urticaria
11/2021
1
Epidermal Nevus
05/2021
1
Chronic Kidney Failure (Chronic Renal Failure)
05/2021
1
Cutaneous Leishmaniasis
05/2021
1
Purpura
03/2021
1
Hemangioma (Angioma)
03/2021
1
Corneal Injuries
02/2021
1
Nevus of Ota
02/2021
1
Hypopigmentation (Hypomelanosis)
02/2021
1
Lichen Sclerosus et Atrophicus (Lichen Sclerosus)
01/2021
1
Breast Neoplasms (Breast Cancer)
01/2021
1
Hidradenitis Suppurativa
11/2020
1
Melanosis (Freckles)
09/2020
1
Fistula
01/2020
1
Erectile Dysfunction
01/2020
1
Chronic Disease (Chronic Diseases)
01/2020
1
Osteonecrosis (Kienbock's Disease)
01/2020
1
Calcinosis
01/2020
1
Acrodermatitis (Gianotti Crosti Syndrome)
01/2020
Drug/Important Bio-Agent (IBA)
5
Pharmaceutical Preparations
IBA
08/2021 - 01/2019
4
Biological Products
IBA
11/2020 - 01/2019
2
dupilumab
IBA
05/2022 - 01/2022
2
ixekizumab
IBA
05/2021 - 01/2020
2
Interleukins
IBA
11/2020 - 11/2020
1
mRNA Vaccines
IBA
02/2022
1
Excipients (Suspending Agents)
IBA
02/2022
1
Vaccines
IBA
02/2022
1
Alkaloids
IBA
01/2022
1
Colchicine
FDA Link
Generic
01/2022
1
Monoclonal Antibodies
IBA
01/2022
1
Chromium
IBA
12/2021
1
Heavy Metals
IBA
12/2021
1
Arsenic
IBA
12/2021
1
Omalizumab (Xolair)
FDA Link
11/2021
1
Hydroxychloroquine (Plaquenil)
FDA Link
Generic
08/2021
1
Imiquimod (Aldara)
FDA Link
Generic
06/2021
1
Rifamycins
IBA
05/2021
1
palbociclib
IBA
01/2021
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
01/2021
1
abemaciclib
IBA
01/2021
1
Acids
IBA
01/2021
1
Hormones (Hormone)
IBA
01/2021
1
1-phenyl-3,3-dimethyltriazene (PDT)
IBA
01/2021
1
Proteins (Proteins, Gene)
FDA Link
01/2021
1
ErbB Receptors (EGF Receptor)
IBA
01/2021
1
Cyclin-Dependent Kinase 4
IBA
01/2021
1
Steroids
IBA
01/2021
1
ribociclib
IBA
01/2021
1
Cytokines
IBA
11/2020
1
Interleukin-23 (Interleukin 23)
IBA
11/2020
1
risankizumab
IBA
11/2020
1
Histamine Antagonists (Antihistamines)
IBA
01/2020
1
Insulin (Novolin)
FDA Link
01/2020
1
Calcium
IBA
01/2020
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2020
1
Aerosols
IBA
01/2020
1
Suspensions
IBA
01/2020
1
Vitamins
IBA
01/2020
Therapy/Procedure
12
Therapeutics
05/2022 - 10/2018
10
Lasers (Laser)
05/2022 - 09/2020
9
Gas Lasers
01/2022 - 01/2020
5
Dye Lasers
01/2022 - 03/2021
2
Solid-State Lasers
05/2022 - 01/2022
2
Drug Therapy (Chemotherapy)
01/2021 - 01/2020
1
Operative Surgical Procedures
01/2022
1
Phototherapy (Light Therapy)
10/2021
1
Aftercare (After-Treatment)
05/2021
1
Adjuvant Radiotherapy
04/2021
1
Photochemotherapy (Photodynamic Therapy)
01/2021
1
Injections
01/2020